Oppenheimer Initiates Coverage on PACS Group (NYSE:PACS)

Oppenheimer assumed coverage on shares of PACS Group (NYSE:PACS) in a research note published on Monday, Marketbeat Ratings reports. The firm issued an outperform rating and a $31.00 price objective on the stock.

PACS has been the subject of a number of other research reports. Truist Financial assumed coverage on PACS Group in a report on Monday. They issued a buy rating and a $32.00 price objective for the company. Royal Bank of Canada assumed coverage on PACS Group in a report on Monday. They issued an outperform rating and a $30.00 price objective for the company. Six investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of Buy and a consensus target price of $30.50.

PACS Group Price Performance

NYSE PACS opened at $24.93 on Monday. PACS Group has a 12 month low of $22.61 and a 12 month high of $25.72.

Insider Buying and Selling at PACS Group

In other PACS Group news, CEO Jason Hulse Murray sold 1,607,142 shares of the business’s stock in a transaction dated Monday, April 15th. The stock was sold at an average price of $21.00, for a total value of $33,749,982.00. Following the completion of the transaction, the chief executive officer now directly owns 62,754,551 shares of the company’s stock, valued at $1,317,845,571. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.

PACS Group Company Profile

PACS Group, Inc, through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. The company also provides senior care and independent facilities. It engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is based in Farmington, Utah.